Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Gain Therapeutics
Company

Gain Therapeutics

Tracked across 2 events · 13 articles · First seen Apr 24, 2026 · Last active Jun 10, 2026

Sentiment
40
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 70
Tech
Gain Therapeutics Presents GT-02287 Update
Impact: Gain Therapeutics announced an oral presentation at the 3rd International GBA1 Meeting 2026, providing an update on its lead drug candidate, GT-02287, for Parkinson s disease. This presentation highlights the company's progress in clinical development and could positively impact its stock price.
Apr 24, 2026 · 7 articles
2 10
Business
Gain Therapeutics to present at H.C. Wainwright Summit
Impact: Gain Therapeutics will participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit, providing an opportunity to present its drug candidates and engage with investors, potentially increasing its visibility and investor interest.
Jun 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Gain Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.